Gamunex immune globulin intravenous regulatory update

FDA approved an sBLA from Talecris for Gamunex to treat chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). The drug has Orphan Drug status from FDA for the indication, which is a rare a...